Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SurgEase Innovations has developed and commercialized hardware and software solutions to improve diagnostic accuracy, workflow efficiency, and patient outcomes in colorectal and gastrointestinal care. Their flagship products include the LumenEye X1 portable digital rectoscope for rapid diagnosis, the CHiP® clinical pathway/telestration software for secure data management and collaboration, and an advanced triple-scope imaging system. The company’s technologies are used by clinicians globally to enhance surgical diagnostics. No clinical trial results reported as they are a medtech/device/software firm.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SurgEase Innovations.